
Loading, please wait...

Loading, please wait...

Fortis Healthcare recently released its Fortis Healthcare Q3 results, showing a 22% year-on-year decline in consolidated profit. Although the profit after tax (PAT) reached Rs 197 crore, this figure dropped from Rs 254 crore in the year-ago period. Consequently, the financial landscape reflects both significant operational hurdles and strong underlying revenue growth across its hospital network.
The reported profit includes a net exceptional loss of Rs 45.9 crore. Primarily, this loss stems from a one-time impact related to new labour codes. Moreover, the company balanced this against a reversal of impairment in an associate firm of Rs 9.4 crore. Meanwhile, revenue performed exceptionally well, increasing to Rs 2,265 crore compared to Rs 1,928 crore in the prior fiscal year. Therefore, the core business remains robust despite the temporary bottom-line pressure caused by regulatory adjustments.
Fortis Healthcare MD and CEO, Ashutosh Raghuvanshi, highlighted healthy growth in key specialties during the quarter. Specifically, renal sciences and orthopedics grew by 27% and 20%, respectively, over the previous period. Furthermore, the company is actively expanding its footprint in Bengaluru through recent acquisitions. This move strengthens its presence from 900 beds to a potential capacity of over 1,500 beds. Additionally, management is evaluating further inorganic opportunities within existing clusters to sustain clinical momentum.
Q1: What caused the decline in Fortis Healthcare\'s Q3 net profit?
The profit decline was primarily due to an exceptional loss of Rs 45.9 crore, which was linked to the one-time impact of new labour codes.
Q2: How did the revenue perform during the December 2025 quarter?
Revenue increased significantly to Rs 2,265 crore, representing a healthy rise from Rs 1,928 crore in the same quarter of the previous year.
Q3: Which medical specialties saw the most growth in this period?
Renal sciences and orthopedics were the top-performing specialties, growing by 27% and 20% respectively, indicating high demand for these clinical services.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Fortis Healthcare reported a 22% dip in Q3 profit to Rs 197 crore, impacted by one-time labour code costs, despite a strong 17.5% rise in consolidated reven...
5 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today